Virtu Financial’s AMAG Pharmaceuticals AMAG Stock Holding History

Virtu Financial’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,296	Closed	-$217K	–	2059
2018 Q4	$217K	Buy	+14,296	New	+$272K	0.01%	914

Other funds holding AMAG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Virtu Financial's AMAG Position: Q1 2019 in Review

Virtu Financial sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 14,296 shares — an estimated $217K sold.

Virtu Financial first reported a position in AMAG in Q4 2018 and held it in 1 quarter. The position peaked at $217K in Q4 2018. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

Virtu Financial reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Virtu Financial sold 14,296 AMAG Pharmaceuticals shares in Q1 2019, an estimated $217K.
Virtu Financial first reported a position in AMAG Pharmaceuticals in Q4 2018 and held it in 1 quarter.
Virtu Financial's AMAG Pharmaceuticals position peaked at $217K in Q4 2018.
166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on Virtu Financial's 13F filing for Q1 2019, filed 12 Apr 2019.